GR3022421T3 - Methods for diagnosing human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein - Google Patents

Methods for diagnosing human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein

Info

Publication number
GR3022421T3
GR3022421T3 GR970400145T GR970400145T GR3022421T3 GR 3022421 T3 GR3022421 T3 GR 3022421T3 GR 970400145 T GR970400145 T GR 970400145T GR 970400145 T GR970400145 T GR 970400145T GR 3022421 T3 GR3022421 T3 GR 3022421T3
Authority
GR
Greece
Prior art keywords
acetylneuraminic acid
hydroxyl group
methods
influenza
human influenza
Prior art date
Application number
GR970400145T
Other languages
English (en)
Inventor
Gregory A Turner
James F Maher
C Worth Clinkscales
Michael C Roark
Original Assignee
Symex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symex Corp filed Critical Symex Corp
Publication of GR3022421T3 publication Critical patent/GR3022421T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/075Benzo[b]pyran-2-ones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/11Orthomyxoviridae, e.g. influenza virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyrane Compounds (AREA)
GR970400145T 1989-12-29 1997-01-29 Methods for diagnosing human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein GR3022421T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45880589A 1989-12-29 1989-12-29
PCT/US1990/007681 WO1991009972A1 (en) 1989-12-29 1990-12-27 Methods for diagnosting human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein

Publications (1)

Publication Number Publication Date
GR3022421T3 true GR3022421T3 (en) 1997-04-30

Family

ID=23822154

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400145T GR3022421T3 (en) 1989-12-29 1997-01-29 Methods for diagnosing human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein

Country Status (10)

Country Link
EP (1) EP0507854B1 (el)
JP (1) JP3134999B2 (el)
AT (1) ATE145673T1 (el)
AU (1) AU656721B2 (el)
CA (1) CA2072368C (el)
DE (1) DE69029276T2 (el)
DK (1) DK0507854T3 (el)
ES (1) ES2097804T3 (el)
GR (1) GR3022421T3 (el)
WO (1) WO1991009972A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE182925T1 (de) * 1990-12-31 1999-08-15 Oklahoma Med Res Found Verfahren zum visuellen nachweis der anwesenheit eines virus in einer klinischen probe
EP0746564B1 (en) * 1994-02-25 1998-12-02 E.I. Du Pont De Nemours And Company 4-n-substituted sialic acids and their sialosides
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
DE69721242T2 (de) * 1996-03-01 2004-01-29 Biota Scient Management Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen
US5719020A (en) * 1996-09-25 1998-02-17 Oklahoma Medical Research Foundation 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
US6303764B1 (en) 1998-09-24 2001-10-16 Zymetx, Inc. Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
AU768886B2 (en) * 1998-10-27 2004-01-08 Ibbex, Inc. Chromogenic substrates of sialidase and methods of making and using the same
US6555698B1 (en) * 1998-11-17 2003-04-29 Tropix, Inc. Chemiluminescent substrates for neuraminidase, assays for detection of neuraminidase and kits therefor
US6420552B1 (en) 1999-09-10 2002-07-16 Zymetx, Inc. Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
US20080113924A1 (en) * 2004-12-17 2008-05-15 National Institue Of Advance Industrial Science And Technology Neuramindase Inhibitor
CN105264086B (zh) * 2013-04-01 2018-06-15 贝克顿·迪金森公司 用于流感诊断的方法和试剂盒
WO2015184442A1 (en) 2014-05-30 2015-12-03 Georgia State University Research Foundation Electrochemical methods and compounds for the detection of enzymes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991009975A1 (en) * 1989-12-29 1991-07-11 Symex Corp. Chromogenic 7- or 8-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith
AU7150891A (en) * 1990-01-10 1991-08-05 Symex Corp. Chromogenic 9-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith

Also Published As

Publication number Publication date
EP0507854A1 (en) 1992-10-14
DK0507854T3 (da) 1997-05-12
CA2072368A1 (en) 1991-06-30
CA2072368C (en) 1998-06-30
EP0507854A4 (en) 1992-10-21
ATE145673T1 (de) 1996-12-15
EP0507854B1 (en) 1996-11-27
JP3134999B2 (ja) 2001-02-13
JPH05505099A (ja) 1993-08-05
AU656721B2 (en) 1995-02-16
DE69029276T2 (de) 1997-04-17
AU7164791A (en) 1991-07-24
ES2097804T3 (es) 1997-04-16
WO1991009972A1 (en) 1991-07-11
DE69029276D1 (de) 1997-01-09

Similar Documents

Publication Publication Date Title
GR3022421T3 (en) Methods for diagnosing human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein
Boyd Biochemical and biological evidence of the activity of high potencies
DK130883D0 (da) Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater
DK0393493T3 (da) Fluorerede galdesyrederivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO972459L (no) Nye flersubst DTPA-derivater og deres metallkomplekser, farmasöytiske preparater inneh slike komplekser, deres anv ved diagnostikk og terapi, fremg for fremst av de kompleksdannende midler og komplekser, samt fremg for frems av de farmasöytiske
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
ES8200082A1 (es) Procedimiento para esterilizar un agente de contraste de ra-yos x de m-carboxamido-o-yodo-n-(b-hidroxialcohil)-anilina.
NO871059D0 (no) Nye carboxylsyrederivater, fremgangsmaate for fremstilling av disse, anvendelse derav, saa vel som legemidler inneholdende disse forbindelser.
ATE71113T1 (de) Antibiotikum a 40926 mannosyl aglycon.
ES2095858T3 (es) Sustratos de beta-galactosidasa.
ES2074492T3 (es) Derivados de acidos biliares, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
ATE69953T1 (de) Verwendung von polysulfatierten heparinen.
ATE73782T1 (de) Verfahren und reagenz zur bestimmung von substraten oder enzymaktivitaeten.
ATE76751T1 (de) Verfahren zur isolierung des blutgerinnungsfaktors ix.
Meyer et al. Zone electrophoresis of human parotid saliva in acrylamide gel
BR9804769A (pt) Processo para tratar ou prevenir infecção por pestivìrus em um hospedeiro mamìfero tendo ou sendo suscetìvel a referida infecção,e , para tratar c~elulas de mamìferos em cultura, e, em mamìferos biológicos
AU7176091A (en) Chromogenic 7- or 8-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith
ES2046999T3 (es) Un metodo para la purificacion de interferon.
DE69114707T2 (de) Neue alpha-glukosidaseinhibitoren.
BRPI0407750A (pt) método para detectar a presença de micoplasma em uma amostra de teste, processo para tratar de uma cultura celular para remover a contaminação por micoplasma, uso de fosfato de acetila ou um seu precursor e/ou fosfato de carbamoìla ou um seu precursor, e, kit para uso na detecção de contaminação por micoplasma
AR014969A1 (es) Formulacion que contienen por lo menos una proteina tardia (proteina l) de uno o mas papilomavirus y/o por lo menos una proteina temprana (proteina e) deuno o mas papilomavirus, procedimiento para la preparacion de la formulacion mencionada asi como su utilizacion para la manufactura de un medicamen
AU7150891A (en) Chromogenic 9-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith
WO1989007656A2 (en) Clinical testing, monitoring and pharmaceutical compositions for treatment of auto-immune diseases